Gold nanoparticles cut blood supply to cancerous tumours

Researchers have found that specially engineered gold nanoparticles have the ability to disrupt the blood supply to cancerous tumours.

A team led by Dr Antonios Kanaras showed that these nanoparticles can activate or inhibit genes that are involved in angiogenesis — a complex process responsible for the supply of oxygen and nutrients to most types of cancer.

‘The peptide-functionalised gold nanoparticles that we synthesised are very effective in the deliberate activation or inhibition of angiogenic genes,’ said Kanaras.

The team is said to have gone a step further by controlling the degree of damage to the endothelial cells using laser illumination. Endothelial cells construct the interior of blood vessels and play a pivotal role in angiogenesis. The researchers also found that the gold particles could be used as effective tools in cellular nanosurgery.

‘We have found that gold nanoparticles can have a dual role in cellular manipulation,’ said Kanaras. ‘Applying laser irradiation, we can use the nanoparticles either to destroy endothelial cells, as a measure to cut the blood supply to tumours, or to deliberately open up the cellular membrane in order to deliver a drug efficiently.’

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox